Please use this identifier to cite or link to this item: https://repositorio.unifesp.br/handle/11600/35418
Title: Leishmanicidal activity of an alkenylphenol from Piper malacophyllum is related to plasma membrane disruption
Authors: Oliveira, Alberto de
Mesquita, Juliana T.
Tempone, Andre G.
Lago, Joao Henrique Ghilardi [UNIFESP]
Guimaraes, Elsie F.
Kato, Massuo J.
Universidade Federal de Uberlândia (UFU)
Adolfo Lutz Inst
Universidade Federal de São Paulo (UNIFESP)
Inst Pesquisas Jardim Bot Rio de Janeiro
Universidade de São Paulo (USP)
Keywords: Piper malacophyllum
Piperaceae
Leishmania (L.) infantum chagasi
Trypanosoma cruzi
Gibbilimbol B
Issue Date: 1-Nov-2012
Publisher: Elsevier B.V.
Citation: Experimental Parasitology. San Diego: Academic Press Inc Elsevier Science, v. 132, n. 3, p. 383-387, 2012.
Abstract: Leishmaniasis and Chagas disease are parasitic protozoan infections that affect the poorest population in the world, causing high mortality and morbidity. As a result of highly toxic and long-duration treatments, novel, safe and more efficacious drugs are essential. in this work, the methanol (MeOH) extract from the leaves of Piper malacophyllum (Piperaceae) was fractioned to afford one alkenylphenol, which was characterized as 4-[(3'E)-decenyl]phenol (gibbilimbol B) by spectroscopic methods. Anti-protozoan in vitro assays demonstrated for the first time that Leishmania (L.) infantum chagasi was susceptible to gibbilimbol B. with an in vitro EC50 of 23 mu g/mL against axenic promastigotes and an EC50 of 22 mu g/mL against intracellular amastigotes. Gibbilimbol B was also tested for anti-trypanosomal activity (Trypanosoma cruzi) and showed an EC50 value of 17 mu g/mL against trypomastigotes. To evaluate the cytotoxic parameters, this alkenylphenol was tested in vitro against NCTC cells, showing a CC50 of 59 mu g/mL and absent hemolytic activity at the highest concentration of 75 mu g/mL. Using the fluorescent probe SYTOX Green suggested that the alkenylphenol disrupted the Leishmania plasma membrane upon initial incubation. Further drug design studies aiming at derivatives could be a promising tool for the development of new therapeutic agents for leishmaniasis and Chagas disease. (C) 2012 Elsevier Inc. All rights reserved.
URI: http://repositorio.unifesp.br/handle/11600/35418
ISSN: 0014-4894
Other Identifiers: http://dx.doi.org/10.1016/j.exppara.2012.08.019
Appears in Collections:Em verificação - Geral

Files in This Item:
File Description SizeFormat 
WOS000310497000012.pdf267.93 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.